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 Summary 
Major Depressive Disorder (MDD) is the most severe form of Depression, which is the leading 
cause of disability worldwide. When considering research approaches aimed at understanding 
MDD it is important to evaluate their effectiveness. 
Here, we studied the effectiveness of original studies addressing this disorder using nonhuman 
primate (NHP), and human-based in vitro and in silico research approaches, and compared their 
respective contributions to subsequent medical publications. For each publication we 
conducted a quantitative citation analysis, and a systematic qualitative analysis of citations. 
In the majority of cases, human-based research approaches (both in silico and in vitro) received 
more citations by subsequent human medical publications than NHP studies, and were 
considered to be more relevant to the hypothesis and/or to the methods in the subsequent 
human medical publications. 
The results of this study suggest that in silico and in vitro approaches are taken into account by 
medical researchers more often than NHP-based approaches. In addition, these human-based 
approaches are also cheaper and less ethically contentious than NHP studies. Therefore, we 
suggest that the standard animal-based procedure for testing medical hypotheses should be 
revised, and that more opportunities to further develop human-relevant innovative techniques 
should be created. 
Key-words: major depressive disorder, in silico, nonhuman primate, animal use alternatives, in 
vitro, 3Rs 
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Introduction 
According to the World Health Organization, depression is the leading cause of morbidity 
worldwide. It affects more than 300 million people of all ages and is a major contributor to the 
overall global burden of disease (1). Furthermore, people who suffer from depression are more 
prone to an early death either by suicide or by the development of other conditions such as 
cancer, heart disease or stroke (2, 3). These patients are also more prone to develop other 
disorders like osteoporosis (4), which – even if not life threatening – significantly impacts quality 
of life, public health and national economies. 
Accordingly, there is major investment in research aiming to improve the understanding of 
depression in all its eight forms (5). Major depressive disorder (MDD) is the most severe 
depression type and the third leading cause of years lived with disability (6). Likewise, the only 
available global European studies (from 2004 and 2010) show that MDD was the costliest brain 
disorder in Europe, accounting for at least 1% of the total European economy (7, 8). In the United 
States of America (USA) the economic burden of MDD alone was $210.5 billion in 2010 (9). 
Clinical research is expensive, time-consuming, and potentially ethically contentious. Therefore, 
nonclinical research approaches using non-human animals, and human-based in vitro and in 
silico approaches are seen as valuable tools within the early steps of biomedical research, as 
they might simplify and accelerate drug and treatment discovery. However, to optimize the 
efficiency of nonclinical research it is crucial to evaluate which research approaches can 
potentially deliver better results for patients. 
Since the second half of the twentieth century, animal-based research has been accepted as the 
‘gold standard’ approach for pre-clinical biomedical research and testing (10). Within this 
approach, nonhuman primate (NHP) research has been considered particularly relevant due to 
the similarity to humans of NHPs. However, this same similarity has led to legal protections, 
albeit with important differences, in various regions of the world. For example, Europe (11), USA 
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(12), and New Zealand (13) applied considerable restrictions to the use of NHPs for scientific 
purposes. These restrictions are due to the understanding that laboratory confinement alone, 
as well as the use of invasive or intrusive techniques, has resulted in psychosomatic injuries, 
mutilations, and even physiology traits that have been compared to those of people with Post-
Traumatic Stress Disorder (13-20). Moreover, NHPs are expensive to acquire (21) and are the 
most expensive animals to maintain (22).  
The legislation of several countries (e.g. Directive 2010/63/EU) require for a cost-benefit 
assessment prior conducting a procedure on a non-human animal. The likely harm to the animal 
should be balanced against the potential benefits of each project and the project should only go 
further if the expected benefits outweighs the harms inflicted to the animals involved. 
Considering all the above, it is assumed that when research is conducted on NHPs, it should 
provide highly relevant data that leads to concrete improvements in patient outcomes, due to 
the ethical and economic concerns surrounding this practice. While some authors assert that 
animal research approaches, and NHP approaches in particular, are crucial for biomedical 
progress (23), more evidence-based papers have increasingly shown that the contribution of 
animal-based research for the advancement of human healthcare has been poor (24), namely in 
understanding MDD (25). However, it is yet to be established whether this poor contribution is 
due to the intrinsic limitations that all nonclinical research approaches unavoidably have, or if 
human-based nonclinical research approaches are more effective in helping biomedical 
progress, at least when seeking to understand complex multifactorial origin disorders such as 
MDD.  
In vitro and in silico methods are thought to potentially allow for faster development of medical 
treatments (26, 27) when they rely on human-based knowledge and/or material directly as a 
reference. Usually, they are also more cost effective. However, on one hand these relatively 
recent methods are still judged against the standard biomedical research paradigm: they are 
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considered to be preliminary steps prior to animal-based testing (28), instead of yielding data of 
sufficient value to be used without additional and, many times contradictory, animal testing, . 
On the other hand, combinations of human-relevant methods like in vitro and in silico are 
thought to enable sufficient understanding of a disease in humans, and providing the means to 
test new therapies for specific patients (29).  
To shed light on this debate, this study examines and compares the contribution of NHP, in silico 
and in vitro approaches to human medical publications addressing MDD. This comparison allows 
us to: a) evaluate whether the low transferability of knowledge to clinical research is a common 
trait of all indirect research approaches, and b) evaluate the relevance of each approach to 
human medical studies. 
Considering its dominance within the current pre-clinical research paradigm, we expect NHP 
studies to have a higher contribution to human medical research than in silico and in vitro 
studies. A similar or lower contribution of NHP papers would suggest that clinical research is 
becoming less reliant on more expensive and ethically questionable NHP research, thus 
suggesting that the time for a paradigm shift has come.  
 
Methods  
The design of this study is based on a previously developed method consisting of a quantitative 
citation analysis and systematic qualitative analysis of citations (30). 
 
Quantitative citation analysis 
Bibliographic search 
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Our citation analysis was performed between September 2016 and June 2017. The bibliographic 
database ‘PubMed’ was searched for papers using NHP, in vitro and in silico research approaches 
to investigate MDD. We used Medical Subject Heading (MeSH) search terms: “Depressive 
disorder, major” AND title/abstract: “primate” OR “ape” OR “macaque” OR “macaca” OR 
“rhesus” OR “chimpanzee” OR “bonobo” OR “gorilla” OR “gorila” OR “Pan” OR “orangutang” OR 
“orang-utan” OR “Orang utan” OR “orangutan” OR “ourang-outang” OR “Pongo” OR “gibbon” 
OR “Hylobates” OR “Colobus” OR “Baboon” OR “Papio” OR “Mandrillus” OR “Mandrill” OR 
“Cebus” OR “Cebuella” OR “ Brachyteles” OR “Loris” OR “Nycticebus” OR “lemur “ OR “Callithrix” 
OR “in silico” OR “computer model” OR “mathematical model” OR “computer simulation” OR 
“in vitro” OR “cell culture” Or “culture technique” OR “cell line” OR “organ culture” OR “tissue 
culture”.  MeSH terms are a comprehensive list of key terms related to each human disorder, 
designed to identify all relevant studies in an area (31). So, searching for “Depressive Disorder, 
Major” retrieves other nomenclatures for the same disorder (e.g. Melancholia). There were no 
exclusive MeSH terms for non-human primates, so our search retrieved additional non-human 
animals’ papers that we excluded by hand.  We also excluded all in vitro and in silico located 
papers that resorted to animal data (e.g. rat cell line data).  
We included papers from scientific journals, books, research reports and conference 
proceedings written in English, Portuguese or Italian, which are within our linguistic fluencies. 
We used PubMed filters to exclude review papers (“review”, “systematic review”, “meta-
analysis”, “bibliography”) as well as editorials an other types of  non-research papers  
(“biography”, “auto¬biography”, “comment”, “opinion paper”, “interview”), since our aim was 
to evaluate the impact of original data. We restricted our search to publications prior to 31 
December 2011, to allow adequate time for subsequent citation of papers (32). We retrieved 19 
NHP papers, 29 in silico papers and 38 in vitro papers describing data from original MDD 
research. 
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Citation data 
We performed a citation analysis on the retrieved papers using the cited reference search facility 
within the ‘Web of Science’ bibliographic database. For each retrieved paper, we listed the 
papers that cited it and recorded three types of citation data: the total number of times the 
retrieved paper was cited, the total number of times the retrieved paper was cited per research 
category, and the total number of times the retrieved paper was cited per research subject i.e. 
on MDD or other subjects, as detailed bellow. 
We ascribed each citing paper to one or more of the following eight research categories: 
“invasive animal research papers”, “human research papers”, “review papers”, “editorials”, “in 
vitro papers”, “in silico papers”, “non-invasive animal research papers”  (e.g. observational 
studies with wild animals) and “other human papers” (e.g. on social perceptions). By “human 
research papers” we mean any human-based research that might involve, among other things, 
analysis of biological samples, epidemiological and behavioural studies, medical case studies, 
and clinical studies. Citing papers could be allocated to several categories if they described 
different research approaches. Whenever it was not possible to define the category of the citing 
paper (due to language barriers or absence of the abstract), the paper was labelled as “not 
available” and removed from further analysis. 
Amongst the categories “human research papers”, “in silico papers”, “in vitro papers” and 
“invasive animal research papers”, we also recorded which papers focused on MDD and which 
focused on other subjects. 
Statistical analysis 
To test for differences between the numbers of citations across research approaches we 
implemented three generalized linear models (GLM), each with a Poisson response and a log 
link function. Each model tested one of the following response variables: total number of 
citations, total number of citations by human research papers, and total number of citations by 
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human research papers on MDD. In each model, the type of research approach was the only 
explanatory variable, with three levels: NHP, in silico and in vitro research approaches. The 
GLM’s goodness of fit was evaluated by visual inspection of diagnostic plots. Additionally, we 
used a Gaussian GLM to evaluate if the proportions of citations made by human medical papers, 
and human medical papers on MDD were different across research approaches. The analyses 
were performed in R 3.6.1 (33) using the function glm. Results were considered significant when 
P < 0.05. 
Systematic qualitative analysis of citations 
Papers under the category “human research papers on MDD” were systematically analysed by 
two independent raters to qualitatively evaluate the contribution of each citation of NHP, in 
vitro or in silico research paper to the respective human medical study. 
Each study was rated according to the following classes, defined prospectively, and as in 
Carvalho et al. (30): 
– Redundant: when the cited study was only mentioned amongst other studies as an example. 
When there were multiple studies used as an example of one or more points, the raters were 
instructed to rate the study as redundant only if there were older or human studies stating 
exactly the same points. 
– Minor relevance: when the cited study was cited in the discussion or introduction providing 
information not directly related to the hypothesis explored in the human medical publication. 
– Relevant to the hypothesis: when the cited study was cited in the introduction, providing 
information relevant for the hypothesis explored in the human medical publication. 
– Relevant to the methods: when the human medical publication used the same methodology 
as the cited paper, with the exception of species in the case of NHP papers. 
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A paper considered relevant could be both relevant for the hypothesis and the methods. Other 
options in the classes are mutually exclusive. In all cases, disagreement between the raters was 
resolved via detailed discussions until a consensus was reached. 
Whenever it was not possible to assess the contribution of a cited paper to the citing human 
medical publication due to unavailability of the latter, the paper was labelled as “not available” 
and removed from further analysis. 
We used a statistical test for comparing proportions (Pearson’s chi-squared test implemented 
via via R’s prop.test function) to assess differences between the three types of citations: “NHP 
papers”, “in vitro papers”, and “in silico papers”. Since even for the pair with the largest 
difference the null hypothesis of equal proportions could not be rejected under the usual 
significance levels, we did not attempt corrections for multiple comparisons. 
 
Results 
Citation analysis — NHP Results 
We retrieved 19 papers describing NHP data in the field of MDD research, which were cited, in 
total, 841 times. Of these 19 papers, five described both human and NHP data. 
Citing publications belonged to the following categories: animal research papers (312); followed 
by review papers (245); human research papers (152); in vitro papers (81); in silico papers (14); 
non-invasive animal papers (six); and opinion papers (including editorials, comments or replies 
to comments) (four). Eighty-five citing papers were not categorized due to being unavailable or 
written in a language other than English, Portuguese or Italian. Of the 312 citations by animal 
research papers, 63 were by papers focusing on MDD. Of the 152 citations by human research 
papers, 71 were by papers focusing on MDD. 
Citation analysis – in silico results 
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We retrieved 29 papers describing in silico data regarding MDD research, which were cited, in 
total, 806 times. Of these 29 papers, seven described both patient data and computer 
simulations. 
Citing publications belonged to the following categories:  human research papers (317); followed 
by in silico papers (193); review papers (193); animal research papers (44); in vitro papers and 
editorials (17 on each category). Fifty-eight citing papers were not categorized due to being 
unavailable or written in a language other than English, Portuguese or Italian. 
Of the 317 citations by human research papers, 94 were by papers focusing on MDD. Of the 193 
citations by in silico research papers, 36 were by papers focusing on MDD. 
Citation analysis – in vitro results 
We retrieved 38 papers describing in vitro data regarding MDD research, which were cited, in 
total, 2,574 times. All in vitro papers used samples of human biological material, most of them 
(34 papers) obtained from MDD patients. 
Citing publications belonged to the following categories:  in vitro papers (1,239) resorting to 
human (789), laboratory animals (373) or both (12) biological materials. Nine hundred and 
seventy-eight citations were made by human medical papers (189 of which were solely with 
human participants, without concurrent use of in vitro research approaches’), 844 citations were 
made by review papers, followed by 464 animal papers (79 of which were solely with live animals 
without concurrent use of in vitro research approaches) in vitro methodologies), 27 editorials 
and 16 in silico papers. One hundred and fifty-four citing papers were not categorized due to 
being unavailable or written in a language other than English, Portuguese or Italian. 
Of the 978 citations by human research papers, 482 were by papers focusing on MDD. Of the 
1239 citations by in vitro research papers, 487 were by papers focusing on MDD. 
Comparison of citations of NHP, in vitro and in silico papers 
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Inspection of diagnostic plots showed no reasons for concern regarding the GLM fit. Amongst in 
vitro papers, there was one highly cited (711 citations). We implemented the analysis with and 
without this potential outlier value and found no significant differences between the two. 
GLM showed the total number of citations received, on average. Each NHP paper received 3.73 
(standard error (se): 0.03) citations. In silico papers received less citations (3.29, i.e. -0.44, se: 
0.05) and in vitro papers received more citations (4.23, i.e. +0.5, se: 0.04). Both differences were 
statistically significant (P << 0.0001). 
Regarding average citations by human research papers, each NHP paper was cited 2.03 (se: 0.08) 
times. In comparison to NHPs, both in vitro and in silico papers received higher number of 
citations (+1.09, se: 0.09 and +0.33, se: 0.10, respectively). The differences are statistically 
significant (P < 0.001).  
Concerning citations by human research papers on MDD, each NHP paper was cited, on average, 
1.27 (se: 0.12) times which is not statistically different from in silico citations (-0.12; se: 0.16). In 
vitro papers received, on average, more citations (+1.3, se: 0.13) and the difference is statistically 
significant from NHP (P < 0.001).  
The proportion of citations of NHP papers by human research papers was 0.13 (se: 0.05). This 
proportion is significantly higher in in silico papers (+0.20, se: 0.07, P = 0.004) and in in vitro 
papers (+0.30, se: 0.07, P << 0.0001). The proportion of citations of NHP papers by human 
research papers on MDD was 0.06 (se: 0.03). The proportion of citations by in silico papers was 
not statistically different (+0.06, se: 0.04, P = 0.1389). The proportion of citations by in vitro 
papers (+0.14, se: 0.04) was significantly different from the same proportion in NHP papers (P = 
0.001). 
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Figure 1 illustrates these comparisons.  
 
Systematic qualitative analysis of citations 
Fifty of the 71 (70%) human research papers on MDD that cited NHP papers were available for 
further analysis, along with 401 of the 482 (83%) human research papers on MDD that cited in 
vitro papers, and 58 of the 94 (62%) human research papers on MDD that cited in silico papers. 
Around 16%, 25% and 25% of citations of, respectively, NHP, in vitro and in silico papers were of 
relevance for the hypothesis and/or the methods in the citing human research paper on MDD.  
The statistical test used to compare the proportions did not reveal any significant differences 
between the proportions of citations with relevance between NHP-in vitro, NHP-in silico, and in 
vitro-in silico (P = 0.31, 0.20 and 1). The contingency table is presented in Table 1.  
Discussion 
We quantitatively and qualitatively analysed the contribution of NHP, in vitro and in silico-based 
research to the contemporary understanding of MDD. Of the three approaches studied, NHP-
based research seems to be the one that provides the lowest likelihood of contributing to human 
medical research. Amongst the three research approaches, human-based in vitro seems to be 
the one that influences clinical research the most. However, all approaches seem to be equally 
relevant in informing the hypothesis and/or methods of human medical studies. 
Overall, our results suggest that less funded research approaches (34) are more or equally 
effective in reaching their final goal — informing clinical research to improve human healthcare. 
Our quantitative results show that in silico and in vitro papers are more successful than NHP 
papers in providing contribution to researchers publishing in human medical papers, as the 
proportion of their total citations by human medical papers is higher than the proportion of NHP 
papers cited by human medical papers. NHP papers are mainly cited by subsequent animal 
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experimentation papers, which suggest that they are mainly contributing to subsequent animal 
research rather than contributing to advances in healthcare. In vitro seems to be the most 
effective approach since it was the one receiving significantly more citations by human medical 
papers on MDD or other subjects. 
Of the five NHP papers on MDD we analysed that were relevant to the hypothesis, method or 
both of the citing human research papers on MDD, one described both NHP and human 
research, and its two citing papers referred to the human research data contained within this 
NHP paper. Another one of these five NHP papers on MDD was considered relevant to the 
methods and was cited once. The citing paper described both human and rhesus monkey data, 
and the citation was relevant to the methods used with the rhesus monkeys. After removing 
these cases, only three out of 19 NHP studies were relevant for the hypothesis and/or methods 
of subsequent human medical studies on MDD. 
The results of our citation analysis also suggest that the widely accepted approach to testing 
medical hypotheses — which relies on in vitro and in silico research approaches as a step prior 
to animal testing - is not actually working as intended, since clinical papers tend to cite in silico 
and in vitro papers directly too. However, the citations within human medical publications on 
MDD constituted a low percentage (50% or less) of the total citations received in all three 
categories. This may be explained by the complexity of MDD, which shares genes, phenotypic 
traits and possible neurologic pathways with different disorders. Hence, a human study on 
anorexia might cite a nonclinical study on MDD focused on weight loss, since changes in weight 
is one of the symptoms of MDD.  
As to the qualitative results, the relevance of the retrieved papers for the publications citing 
them seems insufficient in all analysed research approaches. Even though in silico and in vitro 
papers showed higher percentages of cited papers that were relevant for the hypothesis and/or 
methods used by the citing clinical studies, there were no statistical differences between the 
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three approaches. In this case, the effect size observed, where the proportion of citations by 
NHP is much lesser than that of in silico or in vitro suggesting that while not statistically 
significant, due to lack of statistical power, this might be a relevant practical difference. 
Recent advancements in in vitro technologies, such as organs-on-chips (35) or in silico 
technologies, such as advanced artificial Intelligence based on sophisticated machine learning 
tools (36) have been published after 2011. These studies have been excluded from our analysis 
to guarantee sufficient time for citations. However, it is reasonable to expect that these cutting 
edge technologies are currently being widely used to generate new hypothesis in human 
medicine (27). Similarly, induced pluripotent stem cells, though known for more than a decade 
(37), have only recently been recommended for MDD research (38). In light of the above, it 
would be interesting to replicate this study a decade from now to verify (a) if there is an increase 
in the number of citations that in vitro and in silico papers on MDD receive within MDD human 
publications, and (b) if the number of times in which in silico and in vitro papers are cited with 
relevance for the hypothesis and/or methods, within subsequent human publications, has also 
increased. 
We recognize that our study has certain limitations. Due to resource constraints, we were unable 
to use a greater number of search engines (e.g. CAB Abstracts) to increase the likelihood of 
retrieving all in silico, in vitro and NHP papers investigating MDD, which might have increased 
our sample, making it more comprehensive. Similarly, we were unable to examine the reference 
lists of retrieved papers to locate additional relevant papers. This inevitably means that some 
relevant publications may not have been located. Because our sample was small, our results 
should be interpreted with caution. Finally, we are aware of the difficulty in objectively 
determining the relevance of a cited paper to the publication citing it. We have used two 
different raters to decrease errors in assessment. The initial assessment by the raters was 
sometimes divergent, indicating that different raters using the same criteria might have rated 
This is an accepted manuscript of an article published by SAGE Publications in Alternatives to Laboratory Animals. It is not the 
copy of record. Copyright © 2019, SAGE Publications.
some papers differently. However, our experience suggests that these would comprise only a 
small proportion of papers assessed. Despite the limitations of citation analysis and systematic 
qualitative analyses of citations, we consider that the method we followed is useful when 
evaluating the effectiveness of different research approaches, and we hope that similar studies 
will arise investigating different disorders. 
Our results suggest that the contribution of NHPs to contemporary understanding of MDD is 
poor, and that other approaches with potentially superior relevance to humans should be used. 
Our results also shed light on the controversy around the efficacy of NHP based research for 
investigating human disorders. This controversy is longstanding, with some authors claiming 
that their use is crucial for medical advancement (23), while others asserting the opposite (39, 
40). However, ongoing scientific advances in non-animal methods for the acquisition of 
knowledge and the development of new treatments, may provide alternative solutions to help 
sidestep the dilemmas and concerns surrounding NHP use. 
 
Conclusion 
To our knowledge, this is the first study to compare the effectiveness of original studies involving 
the use of NHP, in vitro and in silico research approaches to inform the medical research 
community, at least within the MDD field. Our results suggest that within this field, compared 
to NHP studies, human-based research approaches are more promising in generating new 
hypothesis and methods in clinical research. 
Given the scientific advances in human-based research methods, we suggest that future 
research using our methodology should examine the impact of more recent approaches in 
informing human medical research. Such research could examine if and how the standard 
paradigm for testing medical hypotheses is still being used, from applied research, through 
animal use in preclinical testing, and on to clinical research and development. Such review could 
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provide further insight into how the ‘gold standard’ that considers in vitro and in silico research 
approaches as merely steps prior to animal testing, could be challenged and revised. Given the 
scientific and ethical solutions that innovative human-based approaches are providing, with 
relatively little investment when compared to the investments in animal-based research, a 
reallocation of Research & Development resources is clearly warranted, in favour of MDD 
nonclinical research using human-based approaches. 
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 Citations of NHP papers In silico papers In vitro papers 
Redundant or Minor 
Relevance 42 43 301 
Relevant for the 
Hypothesis or for the 
Methods 
8 15 100 
 
Table 1. Number of citations of redundant or minor relevance and relevant to the hypothesis or 
for the methods by human research papers on MDD. 
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 Fig. 1 Number of citations received by research method. The first row illustrates the total 
number of citations by research method; the second row illustrates the number of citations by 
human medical papers and the third row illustrates the number of citations by human medical 
paper on MDD. For visualization purposes, the largest observation in In vitro, included in the 
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